Joshua Killpack, PA
Physician Assistant · Idaho Falls, IDNPI 1164777181
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Grifols USA, LLC at 40.9% of the total. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 337 payments — averaging $34.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols USA, LLC$5K
- Inspire Medical Systems, Inc.$2K
- GSK$926
- United Therapeutics Corporation$721
- Takeda Pharmaceuticals U.S.A., Inc.$436
- AstraZeneca$415
- plus $2K from 17 others
What the payments were for
- Speaking & faculty fees$3,89534%
- Travel & lodging$1,18710%
- Food & beverage$6,18354%
- Education$2212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Grifols USA, LLC | 64 | $4,695 |
| Inspire Medical Systems, Inc. | 41 | $2,047 |
| GSK | 67 | $926 |
| United Therapeutics Corporation | 33 | $721 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $436 |
| AstraZeneca | 18 | $415 |
| Boehringer Ingelheim | 20 | $323 |
| Baxter Healthcare | 10 | $256 |
| Grifols Shared Services North America, Inc. | 1 | $240 |
| Sanofi-aventis U.S. LLC | 2 | $196 |
| Sanofi | 10 | $194 |
| Harmony Biosciences LLC | 8 | $176 |
| Bayer | 9 | $167 |
| Mylan Specialty L.p. | 7 | $152 |
| Regeneron Healthcare Solutions, Inc. | 8 | $139 |
| Insmed, Inc. | 4 | $79 |
| Philips North America LLC | 4 | $67 |
| Viatris Specialty LLC | 3 | $64 |
| Merck | 2 | $53 |
| Jazz Pharmaceuticals Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $47 |
| Fisher & Paykel Healthcare Inc | 2 | $31 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolastin-C Liquid$3,895
- Inspire$1,478
- TEZSPIRE$101
How this compares
$11,487 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prolastin CAlpha-1-Proteinase Inhibitor | 24 | $347,237 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 232 | $165,906 |
| Dupixent SyringeDupilumab | 25 | $90,806 |
| Spiriva RespimatTiotropium Bromide | 141 | $90,103 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 130 | $70,205 |
| EliquisApixaban | 41 | $31,905 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $26,455 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 33 | $22,770 |
| Incruse ElliptaUmeclidinium Bromide | 25 | $12,849 |
| Arnuity ElliptaFluticasone Furoate | 33 | $11,311 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 488 | $11,258 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $10,564 |
| Pulmicort FlexhalerBudesonide | 17 | $9,723 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $9,259 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 18 | $8,329 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Grifols USA, LLCProlastin C | $4,695 | $347,23724 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta, Breo Ellipta | $926 | $222,095339 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $323 | $168,636289 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler | $415 | $46,74280 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Idaho Falls
- Tyler PondIdaho Falls$13K
- Jed WillardsonIdaho Falls$12K
- Phillip MarloweIdaho Falls$10K
- Tyson ParkerIdaho Falls$10K
- Rebecca NewbyIdaho Falls$9K
- Todd CranorIdaho Falls$9K
- Lindsi GordonIdaho Falls$9K
- Amanda ColemanIdaho Falls$7K
- Alan AdamsIdaho Falls$7K
- Melissa BatesIdaho Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.